Torrent Pharmaceuticals Ltd
NSE :TORNTPHARM BSE :500420 Sector : PharmaceuticalsBuy, Sell or Hold TORNTPHARM? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
23 Apr 2637.40 (1.76%) | 22 Apr 2591.90 (2.07%) | 19 Apr 2539.40 (-0.29%) | 18 Apr 2546.85 (0.36%) | 16 Apr 2537.60 (0.70%) | 15 Apr 2519.85 (-2.24%) | 12 Apr 2577.70 (-0.05%) | 10 Apr 2578.95 (0.03%) | 09 Apr 2578.10 (-0.74%) | 08 Apr 2597.30 (0.78%) | 05 Apr 2577.10 (1.56%) | 04 Apr 2537.55 (-1.97%) | 03 Apr 2588.65 (-2.99%) | 02 Apr 2668.55 (-0.25%) | 01 Apr 2675.35 (2.87%) | 28 Mar 2600.60 (1.10%) | 27 Mar 2572.40 (0.07%) | 26 Mar 2570.50 (0.42%) | 22 Mar 2559.80 (0.21%) | 21 Mar 2554.40 (1.41%) | 20 Mar 2518.95 (0.70%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Neutral
Medium Term Investors
Neutral
Long Term Investors
Very Bullish
Moving Averages
5 DMA
Bullish
2569.6
10 DMA
Bullish
2569.88
20 DMA
Bullish
2580.35
50 DMA
Bullish
2611.52
100 DMA
Bullish
2462.16
200 DMA
Bullish
2202.76
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Apr 23, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 2722.25 | 2683.9 | 2654.34 | - | - |
R2 | 2683.9 | 2660.37 | 2648.69 | 2687.68 | - |
R1 | 2660.65 | 2645.83 | 2643.05 | 2668.21 | 2672.28 |
P | 2622.3 | 2622.3 | 2622.3 | 2626.08 | 2628.11 |
S1 | 2599.05 | 2598.77 | 2631.75 | 2606.61 | 2610.68 |
S2 | 2560.7 | 2584.23 | 2626.11 | 2564.48 | - |
S3 | 2537.45 | 2560.7 | 2620.46 | - | - |
Key Metrics
EPS
34.45
P/E
76.53
P/B
13
Dividend Yield
0.83%
Market Cap
89,258 Cr.
Face Value
5
Book Value
202.85
ROE
20.5%
EBITDA Growth
923 Cr.
Debt/Equity
0.78
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Torrent Pharmaceuticals Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 2481 | 2500 | 2625 | 2686 | 2787 |
PROFIT | 292 | 287 | 378 | 386 | 381.22 |
EPS | 8.63 | 8.48 | 11.18 | 11.39 | 13.1 |
Torrent Pharmaceuticals Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 1930 | 1946 | 2132 | 2161 | 2112 |
PROFIT | 234 | 219 | 323 | 327 | 297 |
EPS | 6.91 | 6.46 | 9.55 | 9.65 | 8.78 |
Profit & Loss (Figures in Rs. Crores)
Torrent Pharmaceuticals Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 4276.38 | 4999.87 | 7060.27 | 6178.72 | 6610.87 | 7646.41 | 8193.74 | 8340.72 | 8630.74 | 9499.1 | |
PROFIT | 658.91 | 739.53 | 1834.37 | 879.74 | 636.59 | 595.93 | 1001.92 | 1239.71 | 1076.48 | 1217.07 | |
EPS | 18.77 | 21.06 | 51.21 | 27.58 | 20.04 | 12.89 | 30.28 | 36.99 | 22.96 | 36.79 |
Torrent Pharmaceuticals Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 3369.8 | 3866.79 | 5782.98 | 4862 | 4809.09 | 6149.41 | 6462.2 | 6719.05 | 6964.83 | 7648.64 | |
PROFIT | 757.1 | 612.66 | 1703.84 | 797.6 | 440.67 | 714.33 | 914.33 | 1125.1 | 984.59 | 1023.42 | |
EPS | 21.68 | 17.29 | 47.3 | 25.24 | 14.24 | 22.03 | 27.73 | 33.62 | 29.29 | 31.06 |
Balance Sheet (Figures in Rs. Crores)
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 169.23 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 |
Reserves Total | 6,028.84 | 5,868.33 | 5,752.55 | 4,738.6 | 4,639.73 | 4,537.57 | 4,265.51 | 3,409.48 | 2,405.94 | 1,817.81 |
Total Shareholders Funds | 6,198.07 | 5,952.95 | 5,837.17 | 4,823.22 | 4,724.35 | 4,622.19 | 4,350.13 | 3,494.1 | 2,490.56 | 1,902.43 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0.52 | 0.49 | 0.46 | 0.43 | 0.4 |
Secured Loans | 4,530 | 3,295.03 | 4,331.79 | 5,179.69 | 5,548.24 | 5,663.03 | 2,496.38 | 2,338.45 | 2,719.12 | 885.34 |
Unsecured Loans | 838.56 | 774.62 | 542.34 | 604.66 | 489.86 | 799.29 | 13.75 | 13.23 | 21.23 | 246.42 |
Total Debt | 5,368.56 | 4,069.65 | 4,874.13 | 5,784.35 | 6,038.1 | 6,462.32 | 2,510.13 | 2,351.68 | 2,740.35 | 1,131.76 |
Other Liabilities | 415.39 | 378.2 | 382.59 | 457.14 | 310.83 | 306.84 | 270.97 | 256.01 | 215 | 200.46 |
Total Liabilities | 11,982.02 | 10,400.8 | 11,093.89 | 11,064.71 | 11,073.28 | 11,391.87 | 7,131.72 | 6,102.25 | 5,446.34 | 3,235.05 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 12,811.62 | 10,728.19 | 10,511.53 | 10,334.13 | 9,935.43 | 9,449.48 | 4,909.8 | 3,793.53 | 3,542.93 | 1,420.04 |
Less: Accumulated Depreciation | 4,690.17 | 4,305.54 | 3,446.9 | 2,801.01 | 2,187.72 | 1,594.8 | 1,221.36 | 934.45 | 710.27 | 544.7 |
Net Block | 8,121.45 | 6,422.65 | 7,064.63 | 7,533.12 | 7,747.71 | 7,854.68 | 3,688.44 | 2,859.08 | 2,832.66 | 875.34 |
Capital Work in Progress | 765.4 | 629.82 | 889.38 | 711.93 | 617.12 | 646.94 | 519.49 | 1,041.58 | 678.33 | 534.11 |
Investments | 198.79 | 226.31 | 181.14 | 2.11 | 353.44 | 492.36 | 803.64 | 779.68 | 297.65 | 185.66 |
Inventories | 2,229.64 | 2,462.32 | 2,681.2 | 2,148.22 | 1,935.15 | 1,966.3 | 1,559.15 | 1,357.98 | 1,067.17 | 1,006.06 |
Sundry Debtors | 1,943.82 | 1,632.48 | 1,523.37 | 1,649.34 | 1,435.71 | 1,253.45 | 950.89 | 1,445.09 | 1,587.26 | 1,099.42 |
Cash and Bank Balance | 571.46 | 403.41 | 603.5 | 666.65 | 816.04 | 867.23 | 893.72 | 647.03 | 567.36 | 769.42 |
Loans and Advances | 412.71 | 482.8 | 574.38 | 514.83 | 499.29 | 683.16 | 672.16 | 459.34 | 532.03 | 343.95 |
Total Current Assets | 5,157.63 | 4,981.01 | 5,382.45 | 4,979.04 | 4,686.19 | 4,770.14 | 4,075.92 | 3,909.44 | 3,753.82 | 3,218.85 |
Current Liabilities | 2,202.87 | 2,052.97 | 2,495.71 | 2,491.33 | 2,546.93 | 2,474.66 | 2,167.16 | 2,584.22 | 2,037.81 | 1,623.89 |
Provisions | 425.02 | 452.51 | 485.05 | 453.7 | 493.21 | 376.65 | 301.8 | 199.66 | 230.81 | 163.39 |
Total Current Liabilities & Provisions | 2,627.89 | 2,505.48 | 2,980.76 | 2,945.03 | 3,040.14 | 2,851.31 | 2,468.96 | 2,783.88 | 2,268.62 | 1,787.28 |
Net Current Assets | 2,529.74 | 2,475.53 | 2,401.69 | 2,034.01 | 1,646.05 | 1,918.83 | 1,606.96 | 1,125.56 | 1,485.2 | 1,431.57 |
Deferred Tax Assets | 1,445.12 | 1,400.02 | 1,383.07 | 1,294.84 | 1,189.75 | 275.92 | 309.88 | 516.75 | 84.14 | 65.64 |
Deferred Tax Liability | 1,303.39 | 1,099.93 | 961.41 | 861.63 | 827.4 | 0.04 | 101.41 | 405.31 | 188.84 | 47.48 |
Net Deferred Tax | 141.73 | 300.09 | 421.66 | 433.21 | 362.35 | 275.88 | 208.47 | 111.44 | -104.7 | 18.16 |
Other Assets | 224.91 | 346.4 | 135.39 | 350.33 | 346.61 | 203.18 | 304.72 | 184.91 | 257.2 | 190.21 |
Total Assets | 11,982.02 | 10,400.8 | 11,093.89 | 11,064.71 | 11,073.28 | 11,391.87 | 7,131.72 | 6,102.25 | 5,446.34 | 3,235.05 |
Contingent Liabilities | 150.83 | 128.74 | 122.89 | 129.82 | 125.7 | 122.55 | 109.17 | 95.42 | 33.68 | 48.41 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 169.23 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 |
Reserves Total | 6,286.73 | 6,260.8 | 5,945.48 | 5,036.35 | 4,930.65 | 4,471.87 | 4,369.09 | 3,622.69 | 2,620.97 | 2,205.19 |
Total Shareholders Funds | 6,455.96 | 6,345.42 | 6,030.1 | 5,120.97 | 5,015.27 | 4,556.49 | 4,453.71 | 3,707.31 | 2,705.59 | 2,289.81 |
Secured Loans | 4,365.56 | 3,143.41 | 4,184.78 | 4,991.22 | 5,340.72 | 5,045.27 | 2,431.88 | 2,236.15 | 2,500.05 | 885.34 |
Unsecured Loans | 209.91 | 204.1 | 219.36 | 303.12 | 282.35 | 799.29 | 13.75 | 13.23 | 21.23 | 246.33 |
Total Debt | 4,575.47 | 3,347.51 | 4,404.14 | 5,294.34 | 5,623.07 | 5,844.56 | 2,445.63 | 2,249.38 | 2,521.28 | 1,131.67 |
Other Liabilities | 266.87 | 217.83 | 200.49 | 251.57 | 176.68 | 164.57 | 133.22 | 123.71 | 104.06 | 84.01 |
Total Liabilities | 11,298.3 | 9,910.76 | 10,634.73 | 10,666.88 | 10,815.02 | 10,565.62 | 7,032.56 | 6,080.4 | 5,330.93 | 3,505.49 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 12,366.86 | 10,002.35 | 9,952.74 | 9,805.61 | 9,568.39 | 8,905.1 | 4,634.19 | 3,531.56 | 3,416.05 | 1,321.29 |
Less : Accumulated Depreciation | 4,395.01 | 3,751.1 | 3,211.5 | 2,608.11 | 2,143.24 | 1,476.57 | 1,110.7 | 850.17 | 652.55 | 485.13 |
Net Block | 7,971.85 | 6,251.25 | 6,741.24 | 7,197.5 | 7,425.15 | 7,428.53 | 3,523.49 | 2,681.39 | 2,763.5 | 836.16 |
Capital Work in Progress | 697.93 | 567.5 | 588.11 | 536.41 | 497.58 | 447.38 | 473.07 | 983.69 | 627.78 | 507.58 |
Investments | 361.21 | 367.64 | 313.92 | 134.89 | 486.22 | 625.05 | 935.84 | 918.15 | 433.83 | 321.86 |
Inventories | 1,602.23 | 1,797.11 | 1,911.74 | 1,507.76 | 1,358.3 | 1,299.4 | 1,032.29 | 970.13 | 781.15 | 694.51 |
Sundry Debtors | 1,729.44 | 1,541.35 | 1,544.26 | 1,508.94 | 1,356.01 | 1,108.04 | 1,018.47 | 911.5 | 1,181.32 | 1,317.43 |
Cash and Bank Balance | 147.61 | 69.46 | 66.42 | 390.95 | 237.84 | 57.09 | 78.22 | 82.37 | 69.68 | 218.49 |
Loans and Advances | 291.71 | 468.15 | 480.41 | 411.59 | 445.45 | 699.39 | 629.17 | 409.56 | 403.32 | 269.42 |
Total Current Assets | 3,770.99 | 3,876.07 | 4,002.83 | 3,819.24 | 3,397.6 | 3,163.92 | 2,758.15 | 2,373.56 | 2,435.47 | 2,499.85 |
Current Liabilities | 1,021.7 | 927.9 | 1,019.48 | 1,123.82 | 1,120.67 | 1,174.39 | 862.22 | 989.89 | 807.88 | 640.54 |
Provisions | 150.63 | 120.34 | 106.83 | 93.77 | 84.07 | 80.06 | 55.4 | 46.95 | 169.26 | 139.19 |
Total Current Liabilities & Provisions | 1,172.33 | 1,048.24 | 1,126.31 | 1,217.59 | 1,204.74 | 1,254.45 | 917.62 | 1,036.84 | 977.14 | 779.73 |
Net Current Assets | 2,598.66 | 2,827.83 | 2,876.52 | 2,601.65 | 2,192.86 | 1,909.47 | 1,840.53 | 1,336.72 | 1,458.33 | 1,720.12 |
Deferred Tax Assets | 612.85 | 796.86 | 1,026.91 | 1,003.33 | 848.97 | 0.82 | 0 | 117.89 | 31.83 | 26.96 |
Deferred Tax Liability | 1,014.15 | 990.42 | 998.58 | 935.57 | 856.48 | 0 | 100.73 | 289.19 | 220.67 | 74.42 |
Net Deferred Tax | -401.3 | -193.56 | 28.33 | 67.76 | -7.51 | 0.82 | -100.73 | -171.3 | -188.84 | -47.46 |
Other Assets | 69.95 | 90.1 | 86.61 | 128.67 | 220.72 | 154.37 | 360.36 | 331.75 | 236.33 | 167.23 |
Total Assets | 11,298.3 | 9,910.76 | 10,634.73 | 10,666.88 | 10,815.02 | 10,565.62 | 7,032.56 | 6,080.4 | 5,330.93 | 3,505.49 |
Contingent Liabilities | 1,017.36 | 928.05 | 126.18 | 132.56 | 128.58 | 125.48 | 112.09 | 98.41 | 562.25 | 51.46 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 1,847.16 |
Depreciation | 706.59 |
Interest (Net) | 318.66 |
P/L on Sales of Assets | -21.62 |
P/L on Sales of Invest | -19.51 |
Prov. and W/O (Net) | 2.27 |
P/L in Forex | -49.15 |
Total Adjustments (PBT and Ext... | 937.24 |
Operating Profit before Workin... | 2,784.4 |
Trade and 0ther Receivables | -289.72 |
Inventories | 255.71 |
Trade Payables | -58.02 |
Loans and Advances | -19.28 |
Total Adjustments (OP before W... | -18.2 |
Cash Generated from/(used in) ... | 2,766.2 |
Direct Taxes Paid | -398.07 |
Total Adjustments(Cash Generat... | -398.07 |
Cash Flow before Extraordinary... | 2,368.13 |
Net Cash from Operating Activi... | 2,368.13 |
Purchased of Fixed Assets | -573.94 |
Sale of Fixed Assets | 158.71 |
Sale of Investments | 47.4 |
Interest Received | 12.9 |
Acquisition of Companies | -2,000 |
Net Cash used in Investing Act... | -2,335.36 |
Proceed from 0ther Long Term B... | 1,395 |
Proceed from Short Tem Borrowi... | 842.03 |
Of the Long Tem Borrowings | -971.84 |
Of Financial Liabilities | -21.77 |
Dividend Paid | -863.04 |
Interest Paid | -303.02 |
Net Cash used in Financing Act... | 77.36 |
Net Profit before Tax and Extr... | 1,577.02 |
Depreciation | 672.34 |
Interest (Net) | 286.53 |
P/L on Sales of Assets | -22.45 |
P/L on Sales of Invest | -19.51 |
Prov. and W/O (Net) | 0.35 |
P/L in Forex | 73.23 |
Total Adjustments (PBT and Ext... | 990.49 |
Operating Profit before Workin... | 2,567.51 |
Trade and 0ther Receivables | -167.39 |
Inventories | 217.56 |
Trade Payables | -75.78 |
Loans and Advances | -101.41 |
Total Adjustments (OP before W... | -29.64 |
Cash Generated from/(used in) ... | 2,537.87 |
Direct Taxes Paid | -272.46 |
Total Adjustments(Cash Generat... | -272.46 |
Cash Flow before Extraordinary... | 2,265.41 |
Net Cash from Operating Activi... | 2,265.41 |
Purchased of Fixed Assets | -570.9 |
Sale of Fixed Assets | 155.18 |
Sale of Investments | 47.4 |
Interest Received | 9.27 |
Acquisition of Companies | -2,021.09 |
Net Cash used in Investing Act... | -2,325.75 |
Proceed from 0ther Long Term B... | 1,395 |
Proceed from Short Tem Borrowi... | 797.8 |
Of the Long Tem Borrowings | -971.84 |
Of Financial Liabilities | -4.76 |
Dividend Paid | -863.03 |
Interest Paid | -272.43 |
Net Cash used in Financing Act... | 80.74 |
Company Details
Registered Office |
|
Address | Torrent House, Off Ashram Road |
City | Ahmedabad |
State | Gujarat |
Pin Code | 380009 |
Tel. No. | 91-79-26599000 |
Fax. No. | 91-79-26582100 |
investorservices@torrentpharma.com | |
Internet | http://www.torrentpharma.com |
Registrars |
|
Address | Torrent House |
City | Ahmedabad |
State | Gujarat |
Pin Code | 380009 |
Tel. No. | 91-79-26599000 |
Fax. No. | 91-79-26582100 |
investorservices@torrentpharma.com | |
Internet | http://www.torrentpharma.com |
Management |
|
Name | Designation |
Sudhir Mehta | Chairman Emeritus |
Samir Mehta | Executive Chairman |
Shailesh Haribhakti | Independent Director |
H Khaitan | Independent Director |
Ameera Shah | Independent Director |
Nayantara Bali | Independent Director |
Jinesh Shah | Director (Operation) |
Maurice Chagnaud | Independent Director |
Aman Mehta | Whole Time Director |
Manish Choksi | Independent Director |
Chintan Trivedi | Company Sec. & Compli. Officer |